Wei H - Search Results

1

A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects.

Zhang H, Chen H, Li X, Wu M, Zhu X, Li C, Liu J, Wei H, Hu Y, Wang J, Yang Y, Zhu X, Ding Y. Zhang H, et al. Among authors: wei h. Front Pharmacol. 2021 Mar 17;12:646171. doi: 10.3389/fphar.2021.646171. eCollection 2021. Front Pharmacol. 2021. PMID: 34122068 Free PMC article.

2

Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers.

Li X, Liu C, Zhu X, Wei H, Zhang H, Chen H, Chen G, Yang D, Sun H, Shen Z, Zhang Y, Li W, Yang J, Liu Y, Lai X, Gong Y, Liu X, Li Y, Zhong D, Niu J, Liu B, Ding Y. Li X, et al. Among authors: wei h. Front Pharmacol. 2018 Jun 20;9:643. doi: 10.3389/fphar.2018.00643. eCollection 2018. Front Pharmacol. 2018. PMID: 29973877 Free PMC article.

3

Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects.

Zhang H, Li Q, Zhu X, Li C, Li X, Liu C, Hu Y, Chen G, Wei H, Wang J, Shen Z, Ding Y. Zhang H, et al. Among authors: wei h. Cancer Chemother Pharmacol. 2018 Oct;82(4):615-623. doi: 10.1007/s00280-018-3645-1. Epub 2018 Jul 24. Cancer Chemother Pharmacol. 2018. PMID: 30043208 Clinical Trial.

4

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose and Food Effect Study to Evaluate the Tolerance, Pharmacokinetics of Jaktinib, a New Selective Janus Kinase Inhibitor in Healthy Chinese Volunteers.

Liu J, Lv B, Yin H, Zhu X, Wei H, Ding Y. Liu J, et al. Among authors: wei h. Front Pharmacol. 2020 Dec 14;11:604314. doi: 10.3389/fphar.2020.604314. eCollection 2020. Front Pharmacol. 2020. PMID: 33536914 Free PMC article.

5

A Phase I Clinical Study Comparing the Tolerance, Immunogenicity, and Pharmacokinetics of Proposed Biosimilar BAT1806 and Reference Tocilizumab in Healthy Chinese Men.

Zhang H, Wang H, Wei H, Chen H, Liu J, Li C, Zhu X, Li X, Yu J, Zhou Y, Yang X, Wang Z, Wu M, Ding Y. Zhang H, et al. Among authors: wei h. Front Pharmacol. 2021 Jan 25;11:609522. doi: 10.3389/fphar.2020.609522. eCollection 2020. Front Pharmacol. 2021. PMID: 33569002 Free PMC article.

6

First-in-Human, Double-Blind, Randomized, Placebo-Controlled Trial of TQ-F3083, a New Dipeptidyl Peptidase-4 Inhibitor, in Healthy Chinese Adults.

Liu J, Zhu X, Zhang H, Wei H, Yang D, Xu Z, Huo D, Li X, Ding Y. Liu J, et al. Among authors: wei h. Front Pharmacol. 2021 Jul 22;12:689523. doi: 10.3389/fphar.2021.689523. eCollection 2021. Front Pharmacol. 2021. PMID: 34366847 Free PMC article.

7

A phase I, randomized, double-blinded, single-dose study evaluating the pharmacokinetic equivalence of the biosimilar IBI305 and bevacizumab in healthy male subjects .

Zhang H, Zhu X, Wei H, Li C, Chen H, Li X, Wu M, Liu J, Chen G, Zhou H, Zheng S, Ding Y. Zhang H, et al. Among authors: wei h. Int J Clin Pharmacol Ther. 2019 Mar;57(3):167-174. doi: 10.5414/CP203349. Int J Clin Pharmacol Ther. 2019. PMID: 30663977 Clinical Trial.

8

Impacts of CYP2C19 genetic polymorphisms on bioavailability and effect on platelet adhesion of vicagrel, a novel thienopyridine P2Y₁₂ inhibitor.

Zhang Y, Zhu X, Zhan Y, Li X, Liu C, Zhu Y, Zhang H, Wei H, Xia Y, Sun H, Liu Y, Lai X, Gong Y, Liu X, Li Y, Ding Y, Zhong D. Zhang Y, et al. Among authors: wei h. Br J Clin Pharmacol. 2020 Sep;86(9):1860-1874. doi: 10.1111/bcp.14296. Epub 2020 Jun 17. Br J Clin Pharmacol. 2020. PMID: 32267573 Free PMC article. Clinical Trial.

9

Safety and pharmacokinetics of a new biosimilar trastuzumab (HL02): a Phase I bioequivalence study in healthy Chinese men.

Zhang H, Liu T, Wu M, Wei H, Li C, Li X, Liu J, Chen H, Ding Y, Liu L. Zhang H, et al. Among authors: wei h. Expert Opin Biol Ther. 2022 Feb;22(2):179-186. doi: 10.1080/14712598.2021.1894121. Epub 2021 Mar 17. Expert Opin Biol Ther. 2022. PMID: 33616478 Clinical Trial.

10

Tert-Butylhydroquinone Mitigates T-2-Toxin-Induced Testicular Dysfunction by Targeting Oxidative Stress, Inflammation, and Apoptosis in Rats.

Chen Y, Zhang X, Lan S, Liang S, Zhang M, Zhang S, Liu Y, Li L, Wei H, Zhang S. Chen Y, et al. Among authors: wei h. Toxics. 2024 May 5;12(5):335. doi: 10.3390/toxics12050335. Toxics. 2024. PMID: 38787114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,667 results

Search Page